Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab

Table 3

Qualitative analysis of SD-OCT at different time points.

Number of eyes	Month 0	Month 4	Month 6	Month 12	Month 24
	SRF	26 (59%)	13 (29.5%)	16 (37.2%)	18 (47.3%)	17 (44.7%)
IRF	22 (50%)	9 (20.4%)	9 (20.9%)	20 (52.6%)	16 (42.1%)
No fluid	0 (0%)	18 (59%)	23 (53.4%)	10 (26.3%)	13 (34.3%)
SHE	18 (40.9%)	2 (4.5%)	1 (2.3%)	5 (13.1%)	5 (13.1%)
IS/OS disruptions	19 (43.2%)	17 (38.6%)	16 (37.2%)	17 (44.7%)	30 (78.9%)

SRF: subretinal fluid; IRF: intraretinal fluid; SHE: subretinal hyperreflective exudation; IS/OS: inner segment/outer segment.